Organization Overview
Historical Acquisition Tree
Alternative names
elacestrant (2023)
tagraxofusp-erzs (elzonris) (2018 NDA)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 1)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Preleukemia (Phase 1)
Primary Myelofibrosis (Phase 2)
Syndrome (Phase 1)